Maxcyte (MXCT) Sales of Property, Plant and Equipment (2023)
Maxcyte (MXCT) Sales of Property, Plant and Equipment (2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 8.14 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |